Patents Assigned to MedPointe, Inc.
  • Patent number: 6436926
    Abstract: Compositions comprising 4,4′-methylenebis(tetrahydro-1,2,4-thiadiazine) 1,1,1′,1′,-tetraoxide and their use in treating dermatologic disorders are disclosed.
    Type: Grant
    Filed: September 4, 2001
    Date of Patent: August 20, 2002
    Assignee: MedPointe, Inc.
    Inventor: James C. Costin